Charles River Laboratories International Inc. has announced updated compensation terms for its incoming Chief Executive Officer, Birgit Girshick, effective May 5, 2026. Girshick’s base salary will increase to $1,200,000 as of February 1, 2026, and her target annual cash incentive will rise to 100% of her base salary starting May 1, 2026. She will also receive an initial equity grant valued at $9,000,000, comprised of 80% performance share units and 20% restricted stock units, to be awarded in May 2026. Additionally, should Girshick be terminated without cause before the first anniversary of a change in control, she will be eligible for a severance package including a lump sum payment equal to three times her base salary and target bonus, continued medical benefits and perquisites for three years, and outplacement services. Outgoing CEO James C. Foster will receive a $3,000,000 restricted stock unit grant, vesting over two years, for his service during the 2026 fiscal year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-001603), on January 09, 2026, and is solely responsible for the information contained therein.